LEVI BAUER: Open Payments
NPI 1053024232 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,305 in 107 payments from 19 companies in 2025. Trend: 2023 $849 · 2024 $2,957 · 2025 $2,305
Food & beverage: $2,305
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $707 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $295 |
| GENZYME CORPORATION | 6 | $190 |
| QOL Medical, LLC | 5 | $158 |
| Ardelyx, Inc. | 7 | $119 |
| Aimmune Therapeutics, Inc. | 3 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $85 |
| Ipsen Biopharmaceuticals, Inc | 3 | $80 |
| Janssen Biotech, Inc. | 3 | $73 |
| Madrigal Pharmaceuticals | 3 | $71 |
Products named: RINVOQ, SKYRIZI, ENTYVIO, DUPIXENT, Sucraid, IBSRELA, LINZESS, VOWST.
Industry payments across VA — which companies pay providers there.
